3D Systems (DDD) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Q1 2025 revenue declined 8–8.1% year-over-year to $94.5–$95 million, mainly due to lower materials and product sales, partially offset by hardware and services growth.
Net loss widened to $37.0 million from $16.0 million year-over-year; adjusted EBITDA loss increased to $23.9 million.
Cost reduction initiatives target $70 million in annualized savings by mid-2026, including $50 million ongoing and $20 million incremental for 2025.
The Geomagic asset/software sale completed in April 2025, adding over $100 million in net proceeds and strengthening cash reserves to ~$250 million.
Full-year 2025 guidance was withdrawn due to ongoing market volatility, tariff, and customer CapEx uncertainty.
Financial highlights
Revenue: $94.5–$95 million, down 8–8.1% year-over-year.
Gross profit margin: 34.6% (GAAP), 35.0% (non-GAAP), down from 39.8–40.1% year-over-year.
Net loss: $37.0 million vs. $16.0 million year-over-year; adjusted EBITDA: $(23.9) million vs. $(20.1) million.
Non-GAAP loss per share: $(0.21); GAAP diluted loss per share: $(0.28).
Cash and equivalents: $135 million at quarter-end, increasing to ~$250 million post-Geomagic sale.
Outlook and guidance
Full-year 2025 guidance withdrawn due to unpredictable customer CapEx and tariff environment.
Cost actions are expected to yield $70 million in annualized savings by mid-2026.
Focus remains on achieving profitability and positive cash flow at current revenue levels.
Management optimistic about long-term demand in healthcare, defense, and AI infrastructure.
Latest events from 3D Systems
- Sequential revenue growth and margin gains offset year-over-year declines; outlook remains positive.DDD
Q2 20248 Jul 2026 - 2024 revenue hit $440M; cost cuts and Geomagic sale target break-even EBITDA by Q4 2025.DDD
Q4 20248 Jul 2026 - Plans to raise up to $100M for acquisitions and corporate needs, with broad risk disclosures.DDD
Registration filing22 May 2026 - Revenue up 11%, Healthcare surged 21%, and EBITDA turned positive on higher gross margin.DDD
Q1 202612 May 2026 - Board urges approval of all proposals, emphasizing the Equity Plan's role in talent retention.DDD
Proxy filing30 Apr 2026 - Proxy covers director elections, compensation, auditor, share increase, and incentive plan changes.DDD
Proxy filing8 Apr 2026 - Proxy seeks approval for board elections, compensation, auditor, share increase, and incentive plan.DDD
Proxy filing26 Mar 2026 - Q4 2025 saw 16% sequential growth, margin gains, and $55M in cost savings, led by key segments.DDD
Q4 20259 Mar 2026 - FDA-approved 3D printed dentures and aerospace growth position the business for major expansion.DDD
28th Annual Needham Growth Conference Virtual13 Jan 2026